-Reuters
Taysha Gene Therapies Receives Orphan Drug Designation From European Commission For TSHA-120 For Treatment Of Giant Axon Neuropathy (GAN)
Clinical efficacy data for TSHA-120 provide quantitative evidence of long-term durability across all therapeutic dose cohorts with a 10-point improvement in mean change in MFM32 by Year 3 compared to estimated natural